Ligand Pharmaceuticals, Inc. (LGND)
237.73
+0.73
(+0.31%)
USD |
NASDAQ |
Jun 08, 16:00
237.73
0.00 (0.00%)
After-Hours: 16:35
Ligand Pharmaceuticals Total Assets (Quarterly) : 1.532B for March 31, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Organon & Co. | 13.00B |
| Johnson & Johnson | 200.89B |
| Merck & Co., Inc. | 128.68B |
| ANI Pharmaceuticals, Inc. | 1.422B |
| Corcept Therapeutics, Inc. | 814.88M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 534.78M |
| Shareholders Equity (Quarterly) | 997.32M |
| Debt to Equity Ratio | 0.4532 |
| Current Ratio | 21.28 |
| Net Debt Paydown Yield | -2.22% |